已发表论文

辅酶Q在糖尿病及其常见并发症中的研究进展

 

Authors Xia J, Li X, Bai C, Han X

Received 6 June 2024

Accepted for publication 16 September 2024

Published 3 October 2024 Volume 2024:17 Pages 3629—3641

DOI https://doi.org/10.2147/DMSO.S481690

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Antonio Brunetti

Jingdong Xia,1,2 Xiudan Li,1,2 Chunying Bai,2 Xuchen Han1 

1Affiliated Hospital of Chifeng University, Chifeng, The Inner Mongol Autonomous Region, Chifeng, People’s Republic of China; 2Key Laboratory of Research on Human Genetic Diseases at Universities of Inner Mongolia Autonomous Region, Chifeng, People’s Republic of China

Correspondence: Xuchen Han; Xiudan Li, Email hanxuchen2004@163.com; 1248337580@qq.com

Abstract: Coenzyme Q has garnered significant attention due to its potential role in enhancing cellular energy production and its antioxidant properties. We delve into the therapeutic potential of coenzyme Q in managing diabetes mellitus and its complications, highlighting its capacity to improve mitochondrial function, reduce inflammation and oxidative stress, and correct lipid profiles. Coenzyme Q has shown promise in ameliorating insulin resistance and alleviating complications such as diabetic peripheral neuropathy, kidney disease, retinopathy, and cardiomyopathy. However, its clinical application is limited by poor bio-availability. This review also provides a comprehensive overview of current therapeutic strategies for diabetes complications involving coenzyme Q, including stimulating endogenous synthesis and utilizing carrier transport systems, offering insights into mechanisms for enhancing coenzyme Q bio-availability. These findings suggest that, with improved delivery methods, coenzyme Q could become a valuable adjunct therapy in the management of diabetes mellitus.

Keywords: coenzyme Q, diabetes mellitus, diabetic complications